C L I N I C A L S T U D Y S U M M A R Y

151557_GreenLightSummary_B 5/31/07 4:29 PM Page 4G R E E N L I G H TC L I N I C A L S T U D Y S U M M A R YORIGINAL STUDYStudy & PublicationPhotoselective vaporization ofthe prostate for the treatmentof benign prostatichyperplasia: 12-month resultsfrom the first United StatesMulticenter Prospective trialJournal:J Urol 2004Authors:A.E. TeKey FindingsNumber of PatientsTRUS Prostate Volume: Mean(range)Operative Time: Mean (range)Length of Stay (LOS):(range)No Catheterization:Length of Catheterization hrs. (LOC):Mean (score range)Re-catheterization:Laser: 80W13954.6 ± 31.7(21.0 – 174)38.7 ± 23.3 (21.0 – 174)86% (119 patients) 23 hrs. or less27 patients inpatients 24 – 72 hrs.32% (44/139)14.1 ± 14.7 h (0.0 – 72)5% (7 patients)T.R. MalloyB.S. SteinJ.C. UlchakerU.O. NseyoM. A. HaiR. S. MalekNumber of PatientsProstate Volume% DecreaseMean(score range)AUA Score: % ImprovementMean(score range)12 months(n = 119)37%34.4 ± 14.1(17.2 – 90.3)82%4.3 ± 5.8(0 – 34)Follow up:12 monthsQmax: % ImprovementMean(score range)190%22.6 ± 7.6(4.4 – 52.9)PVR: mL % ImprovementMean(score range)78%24.8 ± 44.1(0 – 285)QOL: % ImprovementMean(score range)77%1.0 ± 1.5(0 – 6)AnesthesiaGeneral: 91 patients / Regional: 48 patientsSexual Activity75 patients sexually active. No adverse eventsfrom PVP on sexual activity or function.Complications% ObservedProlonged Dysuria (> 10 days)9.4% (13 patients)Re-treatment0Urethral Stricture0.7% (1 patient)Bladder Neck Contracture1.4% (2 patients)Transient Haematuria (> 10 days)8.6% (12 patients)UTI-urinary Tract Infection2.2% (3 patients)Clinical Significant Blood Loss0Blood Transfusion0Retrograde Ejaculation36% (27/75 patients)Erectile Dysfunction0Epididymitis0.7% (1 patient)